
Olga V. Tcherkasskaya
Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 928 |
| Issued Applications | 461 |
| Pending Applications | 124 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15492911
[patent_doc_number] => 20200046644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Combination Tablet With Chewable Outer Layer
[patent_app_type] => utility
[patent_app_number] => 16/438204
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438204 | Combination Tablet With Chewable Outer Layer | Jun 10, 2019 | Abandoned |
Array
(
[id] => 17034928
[patent_doc_number] => 20210251886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => ORAL MUCOSAL DELIVERY SYSTEMS COMPRISING MONOPHASIC CONCENTRATE OF TERIPARATIDE
[patent_app_type] => utility
[patent_app_number] => 16/973747
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973747 | ORAL MUCOSAL DELIVERY SYSTEMS COMPRISING MONOPHASIC CONCENTRATE OF TERIPARATIDE | Jun 9, 2019 | Pending |
Array
(
[id] => 15862629
[patent_doc_number] => 20200138718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same
[patent_app_type] => utility
[patent_app_number] => 16/429816
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429816 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | Jun 2, 2019 | Abandoned |
Array
(
[id] => 17256639
[patent_doc_number] => 20210369624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => SOLID ORAL DOSAGE FORM HAVING EXCELLENT DISSOLUTION PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/059970
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059970 | SOLID ORAL DOSAGE FORM HAVING EXCELLENT DISSOLUTION PROPERTIES | May 30, 2019 | Abandoned |
Array
(
[id] => 17256616
[patent_doc_number] => 20210369601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Pharmaceutical Formulation
[patent_app_type] => utility
[patent_app_number] => 17/054945
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054945
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054945 | Pharmaceutical formulation | May 22, 2019 | Issued |
Array
(
[id] => 15738221
[patent_doc_number] => 20200107998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => DISPOSABLE BODY CLEANSING TOWELETTE
[patent_app_type] => utility
[patent_app_number] => 16/417220
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16417220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/417220 | DISPOSABLE BODY CLEANSING TOWELETTE | May 19, 2019 | Abandoned |
Array
(
[id] => 14833149
[patent_doc_number] => 20190274975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => NANOPARTICLES FOR STIMULATING ELASTOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/411927
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411927 | NANOPARTICLES FOR STIMULATING ELASTOGENESIS | May 13, 2019 | Abandoned |
Array
(
[id] => 18043603
[patent_doc_number] => 11517535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Capsules with opacifier
[patent_app_type] => utility
[patent_app_number] => 17/046132
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9316
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046132 | Capsules with opacifier | May 13, 2019 | Issued |
Array
(
[id] => 19882950
[patent_doc_number] => 12268632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Self-retaining implantable drug delivery device
[patent_app_type] => utility
[patent_app_number] => 16/411111
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 26
[patent_no_of_words] => 20431
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411111 | Self-retaining implantable drug delivery device | May 12, 2019 | Issued |
Array
(
[id] => 16776402
[patent_doc_number] => 20210113479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => DOSAGE FORMS FOR DELIVERY OF MEDICINES TO THE LOWER GASTROINTESTINAL TRACT
[patent_app_type] => utility
[patent_app_number] => 17/052036
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052036
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052036 | DOSAGE FORMS FOR DELIVERY OF MEDICINES TO THE LOWER GASTROINTESTINAL TRACT | May 2, 2019 | Abandoned |
Array
(
[id] => 14743693
[patent_doc_number] => 20190255020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 16/403176
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403176 | Secnidazole for use in the treatment of bacterial vaginosis | May 2, 2019 | Issued |
Array
(
[id] => 17768152
[patent_doc_number] => 11400070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Methods of treating retinal diseases
[patent_app_type] => utility
[patent_app_number] => 16/401385
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 6383
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16401385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/401385 | Methods of treating retinal diseases | May 1, 2019 | Issued |
Array
(
[id] => 16990428
[patent_doc_number] => 20210228848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Tailorable Medicinally Coated Floss for the Treatment of Gum Disease
[patent_app_type] => utility
[patent_app_number] => 17/050961
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050961 | Tailorable medicinally coated floss for the treatment of gum disease | Apr 30, 2019 | Issued |
Array
(
[id] => 17774810
[patent_doc_number] => 20220241159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COSMETIC COMPOSITIONS IN A SOFT-SOLID FORMAT COMPRISING A HYDROPHOBIC POWDER SELECTED FROM SILICA AEROGEL AND POLYLACTIC ACID, STARCH AND AN UV-FILTER SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/594739
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594739 | COSMETIC COMPOSITIONS IN A SOFT-SOLID FORMAT COMPRISING A HYDROPHOBIC POWDER SELECTED FROM SILICA AEROGEL AND POLYLACTIC ACID, STARCH AND AN UV-FILTER SYSTEM | Apr 29, 2019 | Pending |
Array
(
[id] => 17005276
[patent_doc_number] => 20210236437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/049795
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049795 | SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR | Apr 22, 2019 | Abandoned |
Array
(
[id] => 15020781
[patent_doc_number] => 20190321395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => TREATMENT OF PSORIASIS, SEBORRHEIC DERMATITIS, AND ECZEMA OF THE HEAD AND NECK
[patent_app_type] => utility
[patent_app_number] => 16/390282
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390282
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/390282 | TREATMENT OF PSORIASIS, SEBORRHEIC DERMATITIS, AND ECZEMA OF THE HEAD AND NECK | Apr 21, 2019 | Abandoned |
Array
(
[id] => 19472623
[patent_doc_number] => 12102686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Delivery systems and methods for reactive hydroxyl-containing compounds
[patent_app_type] => utility
[patent_app_number] => 16/385854
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14290
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16385854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/385854 | Delivery systems and methods for reactive hydroxyl-containing compounds | Apr 15, 2019 | Issued |
Array
(
[id] => 14990733
[patent_doc_number] => 20190314324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => COMBINATION OF MICHELIOLIDE DERIVATIVES OR NANOPARTICLES WITH IONIZING RADIATION AND CHECKPOINT INHIBITORS FOR CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/381774
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381774 | COMBINATION OF MICHELIOLIDE DERIVATIVES OR NANOPARTICLES WITH IONIZING RADIATION AND CHECKPOINT INHIBITORS FOR CANCER THERAPY | Apr 10, 2019 | Abandoned |
Array
(
[id] => 19151400
[patent_doc_number] => 11976300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells
[patent_app_type] => utility
[patent_app_number] => 17/046383
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 6865
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046383 | Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells | Apr 10, 2019 | Issued |
Array
(
[id] => 14990643
[patent_doc_number] => 20190314279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => AMLODIPINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/381575
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381575 | Amlodipine formulations | Apr 10, 2019 | Issued |